The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma

Clinical trial NCT04860700 · COMPLETED

Trial details

NCT number: NCT04860700
Sponsor: Peking Union Medical College Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Adrenal Gland Pheochromocytoma Malignant Paraganglioma Pheochromocytoma, Metastatic Paraganglioma, Malignant Paraganglioma, Extra-Adrenal

Start date: 2021-04-30
Primary completion: 2023-10-17
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.